Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
1.260
0.00 (0.00%)
At close: Apr 10, 2026, 4:00 PM EDT
1.270
+0.010 (0.79%)
After-hours: Apr 10, 2026, 4:04 PM EDT
Bone Biologics Market Cap
Bone Biologics has a market cap or net worth of $2.26 million as of April 10, 2026. Its market cap has decreased by -19.57% in one year.
Market Cap
2.26M
Enterprise Value
-3.07M
1-Year Change
-19.57%
Ranking
Category
Stock Price
$1.26
Market Cap Chart
Since March 31, 2016, Bone Biologics's market cap has decreased from $155.72M to $2.26M, a decrease of -98.55%. That is a compound annual growth rate of -34.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 2.26M | -13.10% |
| Dec 31, 2025 | 2.60M | 12.38% |
| Dec 31, 2024 | 2.32M | -4.06% |
| Dec 29, 2023 | 2.41M | -24.75% |
| Dec 30, 2022 | 3.21M | -91.19% |
| Dec 31, 2021 | 36.43M | -58.55% |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GeoVax Labs | 3.05M |
| Calidi Biotherapeutics | 2.85M |
| Oragenics | 2.69M |
| Clearmind Medicine | 2.51M |
| HCW Biologics | 2.27M |
| Adial Pharmaceuticals | 2.23M |
| Biodexa Pharmaceuticals | 2.11M |
| Propanc Biopharma | 2.10M |